This was under news:
Thursday March 5, 3:35 pm Eastern Time
Company Press Release
NASDAQ Investor Forum Exhibitor Profile for Ligand Pharmaceuticals
PHOENIX--(BUSINESS WIRE)--March 5, 1998--The following is a profile for Ligand Pharmaceuticals, who will be an
exhibitor at the NASDAQ Investor Forum, March 7, 1998, at the Phoenix Civic Center Plaza.
Company Name: Ligand Pharmaceuticals
Trading Symbol: LGND
Presentation Date/Time: March 7, 1998, 11 a.m. in Seminar Room D
Company Address: 10275 Science Center Drive
City/State/Zip: San Diego, CA 92121
Investor Relations: Susan Atkins
Investor Relations Phone: 619/550-7500
Industry: Pharmaceutical
Presentation Summary:
Ligand Pharmaceuticals develops drugs that regulate hormone activated intracellular receptors. These receptors play a role in
regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers and cardiovascular,
inflammatory and skin diseases.
Contact:
Ligand Pharmaceuticals, San Diego
Susan Atkins, 619/550-7500 |
